Susan Laura Smith

Insider Reports History

Location
Lambertville, NJ
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Laura Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
Y-mAbs Therapeutics, Inc. SVP & CHIEF COMMERCIAL OFFICER Common Stock 33,918 $561,343 $16.55 05 Mar 2024 Direct
Y-mAbs Therapeutics, Inc. SVP & CHIEF COMMERCIAL OFFICER Employee Stock Option (right to buy) 35,700 18 Jan 2024 Direct

Insider Reports Filed by Susan Laura Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
YMAB Y-mAbs Therapeutics, Inc. 05 Mar 2024 1 -$27,837 4 SVP & CHIEF COMMERCIAL OFFICER 07 Mar 2024, 16:59
YMAB Y-mAbs Therapeutics, Inc. 18 Jan 2024 2 $0 4 SVP & CHIEF COMMERCIAL OFFICER 22 Jan 2024, 18:00
YMAB Y-mAbs Therapeutics, Inc. 26 Jan 2023 1 $0 4 SVP & CHIEF COMMERCIAL OFFICER 30 Jan 2023, 15:32
YMAB Y-mAbs Therapeutics, Inc. 17 Jan 2023 2 $0 4 SVP & CHIEF COMMERCIAL OFFICER 19 Jan 2023, 15:40
YMAB Y-mAbs Therapeutics, Inc. 26 Apr 2022 1 $0 4 SVP & CCO 28 Apr 2022, 18:20
YMAB Y-mAbs Therapeutics, Inc. 14 Dec 2021 1 $0 4 SVP & CCO 23 Dec 2021, 15:55
YMAB Y-mAbs Therapeutics, Inc. 14 Dec 2021 0 $0 3 Senior Vice President, CCO 23 Dec 2021, 15:52